| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | VCX/VCY1 | 2.35e-12 | 5 | 17 | 4 | IPR026653 | |
| Domain | VCX_VCY | 2.35e-12 | 5 | 17 | 4 | PF15231 | |
| Domain | NBPF | 1.03e-07 | 11 | 17 | 3 | PS51316 | |
| Domain | DUF1220 | 1.03e-07 | 11 | 17 | 3 | PF06758 | |
| Domain | NBPF_dom | 1.03e-07 | 11 | 17 | 3 | IPR010630 | |
| Domain | DUF1220 | 2.80e-05 | 9 | 17 | 2 | SM01148 | |
| Pubmed | 1.87e-21 | 21 | 23 | 8 | 16079250 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 2.00e-14 | 10 | 23 | 5 | 22973535 | |
| Pubmed | 1.45e-13 | 4 | 23 | 4 | 10903929 | ||
| Pubmed | 2.53e-10 | 3 | 23 | 3 | 18076704 | ||
| Pubmed | 2.52e-09 | 5 | 23 | 3 | 10607842 | ||
| Pubmed | 2.91e-08 | 513 | 23 | 7 | 25798074 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 8.24e-08 | 170 | 23 | 5 | 23314748 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 12862317 | ||
| Pubmed | Modulation of neuritogenesis by a protein implicated in X-linked mental retardation. | 4.18e-07 | 2 | 23 | 2 | 19812318 | |
| Pubmed | 6.26e-06 | 6 | 23 | 2 | 17342728 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 7.90e-06 | 430 | 23 | 5 | 35044719 | |
| Pubmed | Lineage-specific gene duplication and loss in human and great ape evolution. | 1.29e-05 | 69 | 23 | 3 | 15252450 | |
| Pubmed | Characterization of the DOT1L network: implications of diverse roles for DOT1L. | 3.38e-04 | 41 | 23 | 2 | 20431927 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 6.29e-04 | 608 | 23 | 4 | 36089195 | |
| Interaction | NEK4 interactions | 1.32e-06 | 582 | 21 | 7 | int:NEK4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 1.47e-11 | 404 | 23 | 8 | chr1q21 | |
| Cytoband | 1q21.1 | 2.62e-08 | 62 | 23 | 4 | 1q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp22 | 7.01e-06 | 250 | 23 | 4 | chrXp22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p11 | 5.01e-05 | 21 | 23 | 2 | chr1p11 | |
| Cytoband | Xp22 | 7.15e-05 | 25 | 23 | 2 | Xp22 | |
| Cytoband | 1q21.2 | 5.84e-04 | 71 | 23 | 2 | 1q21.2 | |
| Cytoband | 1q21 | 9.57e-04 | 91 | 23 | 2 | 1q21 | |
| Cytoband | 19p13.3 | 6.25e-03 | 237 | 23 | 2 | 19p13.3 | |
| GeneFamily | Neuroblastoma breakpoint family | NBPF10 NBPF8 NBPF19 NBPF14 NBPF26 NBPF15 NBPF20 NBPF9 NBPF12 | 2.40e-22 | 23 | 20 | 9 | 662 |
| GeneFamily | Variable charge X/Y family | 1.63e-11 | 6 | 20 | 4 | 368 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | 2.42e-06 | 746 | 23 | 7 | M40863 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_DN | 2.76e-05 | 203 | 23 | 4 | M15912 | |
| ToppCell | COVID-19_Convalescent|World / Disease condition and Cell class | 3.16e-08 | 181 | 23 | 5 | a62115a8da486fc61225901c72b1ec70bcaf4c36 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-06 | 175 | 23 | 4 | a3f8c54c77bce9b035a4835945ab341909be4946 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-06 | 180 | 23 | 4 | b234668bf181522807470e396792e1b54890b719 | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 2.51e-06 | 189 | 23 | 4 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.14e-06 | 200 | 23 | 4 | f75d95376a340d467c4392b872b2a2dbdd184556 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.14e-06 | 200 | 23 | 4 | 47791c93d03ee17c1ce17e27f075be4fc6f2590e | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.14e-06 | 200 | 23 | 4 | fae26560ba3b0b638b6bcf92f05330824b31d21b | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Chromophobe-6|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.42e-05 | 92 | 23 | 3 | 965a0ebf4b1ad3eaad839b96995ea6712c5d3357 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Mixed_Serous_and_Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.78e-05 | 115 | 23 | 3 | c724e8b1fddcefdaa8d247aaff68c986538068f7 | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.43e-05 | 144 | 23 | 3 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.75e-05 | 155 | 23 | 3 | 5fabe24a784f0be46040ffc886eabd8d5ce78121 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.42e-05 | 167 | 23 | 3 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.35e-05 | 173 | 23 | 3 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 180 | 23 | 3 | 7c7c4d64ff99d0710a7d19d8bc29fc9217394db1 | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 1.12e-04 | 184 | 23 | 3 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-04 | 184 | 23 | 3 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-04 | 185 | 23 | 3 | c3d1a312569f3d619f7295812741cbf068ec6c1f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-04 | 186 | 23 | 3 | 41e03be964044dae690d566bd078dab3d8045eba | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-04 | 187 | 23 | 3 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-04 | 187 | 23 | 3 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-04 | 187 | 23 | 3 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-04 | 187 | 23 | 3 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-04 | 187 | 23 | 3 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-04 | 187 | 23 | 3 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | COPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 1.21e-04 | 189 | 23 | 3 | 6294691231c7d38707323cf31578a107d3b2c622 | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 1.23e-04 | 190 | 23 | 3 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-04 | 190 | 23 | 3 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 1.23e-04 | 190 | 23 | 3 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-04 | 190 | 23 | 3 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | COPD-Myeloid-ncMonocyte|COPD / Disease state, Lineage and Cell class | 1.29e-04 | 193 | 23 | 3 | 936ca95995599356b794fba32bfd82d8de339365 | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 1.33e-04 | 195 | 23 | 3 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 1.33e-04 | 195 | 23 | 3 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-04 | 195 | 23 | 3 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 198 | 23 | 3 | efdbac7a3a02bff4ca48841772e0c136556c2b9b | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 198 | 23 | 3 | a631be84e29c277216d89ec6265bd43e87c1dc86 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.44e-04 | 200 | 23 | 3 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.44e-04 | 200 | 23 | 3 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.44e-04 | 200 | 23 | 3 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.44e-04 | 200 | 23 | 3 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.44e-04 | 200 | 23 | 3 | f861509b54185d89931db64da1b9d81986cc7938 | |
| Drug | Pesticides | 5.56e-13 | 150 | 21 | 8 | ctd:D010575 | |
| Drug | DB07586 | 4.20e-05 | 74 | 21 | 3 | CID005287979 | |
| Disease | anthropometric measurement | 7.84e-05 | 168 | 15 | 3 | EFO_0004302 | |
| Disease | revision of total hip arthroplasty, aseptic loosening | 2.05e-04 | 42 | 15 | 2 | EFO_0010725, EFO_0020973 | |
| Disease | axial length measurement | 6.90e-04 | 77 | 15 | 2 | EFO_0005318 | |
| Disease | Crohn's disease | 1.32e-03 | 441 | 15 | 3 | EFO_0000384 | |
| Disease | lymphocyte percentage of leukocytes | 4.24e-03 | 665 | 15 | 3 | EFO_0007993 | |
| Disease | neuropsychological test | 4.40e-03 | 197 | 15 | 2 | EFO_0003926 | |
| Disease | lymphocyte count | 5.30e-03 | 1464 | 15 | 4 | EFO_0004587 | |
| Disease | systemic lupus erythematosus | 7.06e-03 | 799 | 15 | 3 | MONDO_0007915 | |
| Disease | Drugs used in diabetes use measurement | 7.25e-03 | 255 | 15 | 2 | EFO_0009924 | |
| Disease | non-melanoma skin carcinoma | 7.81e-03 | 265 | 15 | 2 | EFO_0009260 | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 9.60e-03 | 295 | 15 | 2 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKGRKMAGRKRGRPK | 401 | Q8TEK3 | |
| DAKRKRGRPRKKSGG | 461 | P48382 | |
| RSKRGGWSKGRKRKK | 81 | Q9NP66 | |
| RGRASKGTGKRRKKR | 1211 | Q27J81 | |
| KGKAVRRGRRGKKGA | 41 | Q9NNX9 | |
| KGKAVRRGRRGKKGA | 41 | Q9H321 | |
| GKGKIGRGRRSKKKR | 796 | Q3BBV2 | |
| EIEKKGKGKKRRGRR | 826 | P0DPF3 | |
| GKGKKRRGRRSKKKR | 831 | P0DPF3 | |
| IEKKGKGKKRRGRRS | 996 | P0DPF3 | |
| KGKKRRGRRSKKERR | 1001 | P0DPF3 | |
| EIEKKGKGKKRRGRR | 826 | Q6P3W6 | |
| GKGKKRRGRRSKKER | 831 | Q6P3W6 | |
| IEKKGKGKKRRGRRS | 1071 | Q6P3W6 | |
| KGKKRRGRRSKKERR | 1076 | Q6P3W6 | |
| EKKGKGKKRRGRRSK | 1316 | Q6P3W6 | |
| KGKGKKRRGRRSKKE | 1806 | Q6P3W6 | |
| EIEKKGKGKKRRGRR | 2046 | Q6P3W6 | |
| GKGKKRRGRRSKKER | 2051 | Q6P3W6 | |
| IEKKGKGKKRRGRRS | 2291 | Q6P3W6 | |
| KGKKRRGRRSKKERR | 2296 | Q6P3W6 | |
| EKKGKGKKRRGRRSK | 2536 | Q6P3W6 | |
| KGKGKKRRGRRSKKE | 3026 | Q6P3W6 | |
| EIEKKGKGKKRRGRR | 3266 | Q6P3W6 | |
| GKGKKRRGRRSKKER | 3271 | Q6P3W6 | |
| IEKKGKGKKRRGRRS | 3511 | Q6P3W6 | |
| KGKKRRGRRSKKERR | 3516 | Q6P3W6 | |
| EKKGKGKKRRGRRSK | 3681 | Q6P3W6 | |
| EIEKKGKGKKRRGRR | 1341 | Q5TAG4 | |
| GKGKKRRGRRSKKKR | 1346 | Q5TAG4 | |
| EIEKKGKGKKRRGRR | 486 | Q5TI25 | |
| GKGKKRRGRRSKKER | 491 | Q5TI25 | |
| IEKKGKGKKRRGRRS | 806 | Q5TI25 | |
| KGKKRRGRRSKKERR | 811 | Q5TI25 | |
| IEKKGKGKKRRGRRS | 556 | Q8N660 | |
| KGKKRRGRRSKKKRR | 561 | Q8N660 | |
| IEKKGKGKKRRGRRS | 556 | A0A087WUL8 | |
| KGKKRRGRRSKKERR | 561 | A0A087WUL8 | |
| EKKGKGKKRRGRRSK | 801 | A0A087WUL8 | |
| KGKGKKRRGRRSKKE | 1291 | A0A087WUL8 | |
| EIEKKGKGKKRRGRR | 1531 | A0A087WUL8 | |
| GKGKKRRGRRSKKER | 1536 | A0A087WUL8 | |
| IEKKGKGKKRRGRRS | 1776 | A0A087WUL8 | |
| KGKKRRGRRSKKERR | 1781 | A0A087WUL8 | |
| EKKGKGKKRRGRRSK | 2021 | A0A087WUL8 | |
| KGKGKKRRGRRSKKE | 2511 | A0A087WUL8 | |
| EIEKKGKGKKRRGRR | 2751 | A0A087WUL8 | |
| GKGKKRRGRRSKKER | 2756 | A0A087WUL8 | |
| IEKKGKGKKRRGRRS | 2996 | A0A087WUL8 | |
| KGKKRRGRRSKKERR | 3001 | A0A087WUL8 | |
| EKKGKGKKRRGRRSK | 3241 | A0A087WUL8 | |
| KGKGKKRRGRRSKKE | 3731 | A0A087WUL8 | |
| EIEKKGKGKKRRGRR | 211 | P0DPF2 | |
| GKGKKRRGRRSKKER | 216 | P0DPF2 | |
| IEKKGKGKKRRGRRS | 456 | P0DPF2 | |
| KGKKRRGRRSKKERR | 461 | P0DPF2 | |
| EKKGKGKKRRGRRSK | 701 | P0DPF2 | |
| KGKGKKRRGRRSKKE | 1191 | P0DPF2 | |
| EIEKKGKGKKRRGRR | 1431 | P0DPF2 | |
| GKGKKRRGRRSKKER | 1436 | P0DPF2 | |
| IEKKGKGKKRRGRRS | 1676 | P0DPF2 | |
| KGKKRRGRRSKKERR | 1681 | P0DPF2 | |
| EKKGKGKKRRGRRSK | 1921 | P0DPF2 | |
| KGKGKKRRGRRSKKE | 2411 | P0DPF2 | |
| EIEKKGKGKKRRGRR | 2651 | P0DPF2 | |
| GKGKKRRGRRSKKER | 2656 | P0DPF2 | |
| IEKKGKGKKRRGRRS | 2896 | P0DPF2 | |
| KGKKRRGRRSKKERR | 2901 | P0DPF2 | |
| EKKGKGKKRRGRRSK | 3141 | P0DPF2 | |
| KGKGKKRRGRRSKKE | 3631 | P0DPF2 | |
| EIEKKGKGKKRRGRR | 3871 | P0DPF2 | |
| GKGKKRRGRRSKKER | 3876 | P0DPF2 | |
| IEKKGKGKKRRGRRS | 4116 | P0DPF2 | |
| KGKKRRGRRSKKERR | 4121 | P0DPF2 | |
| EKKGKGKKRRGRRSK | 4361 | P0DPF2 | |
| KGKGKKRRGRRSKKE | 4851 | P0DPF2 | |
| EIEKKGKGKKRRGRR | 5091 | P0DPF2 | |
| GKGKKRRGRRSKKKR | 5096 | P0DPF2 | |
| EIEKKGKGKKRRGRR | 786 | B4DH59 | |
| GKGKKRRGRRSKKER | 791 | B4DH59 | |
| KRKRDRGAGSKRKRR | 616 | Q9Y2G9 | |
| KGKAVRRGRRGKKGA | 41 | Q9H322 | |
| RKKRGGRRYRKMKER | 351 | Q8WWY3 | |
| CQKGERGKKGRERKR | 206 | Q9BXY4 | |
| KGKAVRRGRRGKKGA | 41 | Q9H320 | |
| GKSNKKRGKLRGRRL | 2601 | Q96JG9 | |
| KARGKKGRRKRKGSF | 46 | Q9Y577 | |
| KRKRRKKRGHGWSRM | 496 | Q13342 |